Related Experiment Video
Updated: Jul 3, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
The Src tyrosine kinase pathway regulates thecal CYP17 expression and androstenedione secretion
Gaurav Chaturvedi1, Koji Arai, Paul F Terranova
1Department of Molecular and Integrative Physiology, The Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Abstract:
In order to evaluate the role of Src tyrosine kinase in thecal cell steroidogenesis, a pharmacological approach was utilized by treating enriched populations of mouse ovarian theca-interstitial cells in vitro with a direct Src kinase inhibitor, PP2. Inhibition of Src with PP2 increased both basal and forskolin-stimulated androstenedione secretion, and increased cytochrome P450 17-alpha hydroxylase-lyase (CYP17) promoter activity and steady state mRNA. PP2 did not change thecal levels of StAR mRNA. Inhibition of mitogen-activated protein kinase kinase, a downstream regulator of Src activity, using PD98059 also increased forskolin-stimulated secretion of androstenedione above forskolin alone, but had no effect on basal secretion of androstenedione. Src inhibition increased mitogen-activated protein kinase phosphatase-1 protein and decreased phosphorylation of SF-1, which correlated with increased CYP17 promoter activity and mRNA levels. These results implicate Src tyrosine kinase in the regulation of CYP17 and thecal androgen secretion.
Insights
Src tyrosine kinase regulates thecal cell steroidogenesis. Inhibiting Src kinase boosts androstenedione secretion and CYP17 gene expression, implicating it in ovarian androgen production.
Area of Science:
- Endocrinology
- Molecular Biology
- Reproductive Science
Background:
- Thecal cells are crucial for ovarian androgen production.
- Src tyrosine kinase is a potential regulator of steroidogenesis.
- Understanding Src's role can elucidate mechanisms of ovarian function.
Purpose of the Study:
- To investigate the role of Src tyrosine kinase in mouse thecal cell steroidogenesis.
- To determine the effect of Src inhibition on androstenedione secretion and CYP17 gene expression.
Main Methods:
- Primary mouse theca-interstitial cells were cultured in vitro.
- Cells were treated with PP2, a Src kinase inhibitor.
- Androstenedione secretion, CYP17 promoter activity, and mRNA levels were measured.
- Downstream signaling pathways, including MAPK and SF-1 phosphorylation, were assessed.
Main Results:
- Src inhibition by PP2 significantly increased basal and forskolin-stimulated androstenedione secretion.
- PP2 treatment elevated CYP17 promoter activity and mRNA levels.
- Src inhibition increased mitogen-activated protein kinase phosphatase-1 and decreased SF-1 phosphorylation.
- Inhibition of a downstream Src target, MAPK kinase, partially mimicked Src inhibition effects.
Conclusions:
- Src tyrosine kinase plays a significant role in regulating CYP17 expression and thecal cell androgen secretion.
- Src acts through downstream signaling pathways involving SF-1 and MAPK to modulate steroidogenesis.
- Targeting Src kinase may offer novel therapeutic strategies for conditions involving altered ovarian androgen production.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
Receptor Tyrosine Kinases
Regulation of Hormone Secretion
Humoral stimuli,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...